Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study).
PLoS One. 2015 Dec 3;10(12):e0143643. doi: 10.1371/journal.pone.0143643. eCollection 2015.
PLoS One. 2015.
PMID: 26633806
Free PMC article.
Clinical Trial.
Strontium-89 plus zoledronic acid versus zoledronic acid for patients with painful bone metastatic breast cancer.
Yamada K, Kaise H, Taguchi T, Horiguchi J, Takao S, Suzuki M, Kubota T, Miura D, Narui K, Tawaraya K, Machida Y, Akazawa K, Kohno N, Ishikawa T; JONIE Study Group.
Yamada K, et al.
J Bone Miner Metab. 2022 Nov;40(6):998-1006. doi: 10.1007/s00774-022-01366-y. Epub 2022 Aug 30.
J Bone Miner Metab. 2022.
PMID: 36042056
Clinical Trial.
Item in Clipboard
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment.
Hayashi M, Nakazawa K, Hasegawa Y, Horiguchi J, Miura D, Ishikawa T, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Tanino H, Yamada K, Narui K, Kimura K, Akazawa K, Kohno N; JONIE STUDY GROUP.
Hayashi M, et al.
Anticancer Res. 2019 Aug;39(8):4305-4314. doi: 10.21873/anticanres.13596.
Anticancer Res. 2019.
PMID: 31366522
Clinical Trial.
Item in Clipboard
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study.
Yamada A, Nakazawa K, Akazawa K, Narui K, Endo I, Hasegawa Y, Kohno N, Ishikawa T; JONIE STUDY GROUP.
Yamada A, et al.
Anticancer Res. 2021 Feb;41(2):1063-1068. doi: 10.21873/anticanres.14863.
Anticancer Res. 2021.
PMID: 33517316
Clinical Trial.
Item in Clipboard
Cite
Cite